Skip to main content
logo
Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
3.780
0.00 (0.00%)
Aug 6, 2026, 10:30 AM EDT - Market open

Opus Genetics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
31214038---
Market Cap Growth
384.37%273.90%----
Enterprise Value
269.8195.426.09000
Last Close Price
3.782.011.19---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-6.026.026.0214.08-
PS Ratio
32.719.903.42---
PB Ratio
-9.155.59---
P/TBV Ratio
-8.154.73---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
27.386.722.37---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-2.6900000.02
Net Debt / Equity Ratio
4.15-2.94-4.51-1.01-0.92-1.09
Net Debt / EBITDA Ratio
1.071.170.494.79-2.341.07
Net Debt / FCF Ratio
-1.281.1945.43-2.981.25
Asset Turnover
0.140.330.240.371.060.03
Quick Ratio
11.876.203.2013.0817.276.42
Current Ratio
12.196.433.2413.3517.796.76
Return on Equity (ROE)
-9111.77%-449.36%-203.19%-20.77%52.26%-1295.10%
Return on Assets (ROA)
-70.68%-88.63%-136.71%-20.55%47.72%-103.77%
Return on Invested Capital (ROIC)
-70.88%---717.97%2291.82%-363.16%
Return on Capital Employed (ROCE)
-79.18%-113.48%-164.49%-21.97%53.24%-123.67%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-117.13%-132.91%-23.74%-4.82%-38.68%-218.65%
Total Shareholder Return
-117.13%-132.91%-23.74%-4.82%-38.68%-218.65%
SEC Filings: 10-K · 10-Q